Biocatalysts for natural product biosynthesis

Annual Review of Chemical and Biomolecular Engineering

Volumn 5, Issue , 2014, Pages 347-366

  Tibrewal, Nidhi ^a   Tang, Yi ^a,b  

^a Department of Chemical and Biomolecular Engineering ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Domain swapping; Protein engineering; Total in vitro biosynthesis

Indexed keywords

BIOACTIVITY; BIOCHEMICAL ENGINEERING; BIOSYNTHESIS; GENES; KETONES; BIOCATALYSTS; BIOCHEMISTRY; METABOLISM; SYNTHESIS (CHEMICAL);

BIOSYNTHETIC PATHWAY; CHIRAL BUILDING BLOCKS; DOMAIN SWAPPING; IN-VITRO; LARGE SCALE SYNTHESIS; PHARMACEUTICAL SYNTHESIS; PROTEIN ENGINEERING; SECONDARY METABOLISM;

ENZYMES;

BIOLOGICAL PRODUCT; DRUG; ENZYME; POLYKETIDE;

BIOCATALYSIS; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; DOMAIN SWAPPING; METABOLISM; METHODOLOGY; PHARMACEUTICS; PROTEIN ENGINEERING; REVIEW; TOTAL IN VITRO BIOSYNTHESIS;

DOMAIN SWAPPING; PROTEIN ENGINEERING; TOTAL IN VITRO BIOSYNTHESIS;

BIOCATALYSIS; BIOLOGICAL PRODUCTS; BIOSYNTHETIC PATHWAYS; ENZYMES; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; POLYKETIDES; TECHNOLOGY, PHARMACEUTICAL;

EID: 84902529309     PISSN: 19475438     EISSN: None     Source Type: Journal    
DOI: 10.1146/annurev-chembioeng-060713-040008     Document Type: Review

References (117)

1. Butler MS. 2008. Natural products to drugs: natural product-derived compounds in clinical trials. Nat. Prod. Rep. 25:475-516
2. Hertweck C. 2009. The biosynthetic logic of polyketide diversity. Angew. Chem. Int. Ed. 48:4688-716
3. Li JWH, Vederas JC. 2009. Drug discovery and natural products: End of an era or an endless frontier Science 325:161-65
4. Newman DJ, Cragg GM. 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75:311-35
5. Schoemaker HE,MinkD, WubboltsMG.2003. Dispelling the myths: biocatalysis in industrial synthesis. Science 299:1694-97
6. Huisman GW, Collier SJ. 2013. On the development of new biocatalytic processes for practical pharmaceutical synthesis. Curr. Opin. Chem. Biol. 17:284-92
7. Bornscheuer UT, Huisman GW, Kazlauskas RJ, Lutz S, Moore JC, Robins K. 2012. Engineering the third wave of biocatalysis. Nature 485:185-94
8. Savile CK, Janey JM, Mundorff EC,Moore JC, Tam S, et al. 2010. Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture. Science 329:305-9
9. Zabala AO, Cacho RA, Tang Y. 2012. Protein engineering towards natural product synthesis and diversification. J. Ind. Microbiol. Biotechnol. 39:227-41
10. DunnBJ,KhoslaC. 2013. Engineering the acyltransferase substrate specificity of assembly line polyketide synthases. J. R. Soc. Interface 10:20130297
11. Johannes TW, Zhao HM. 2006. Directed evolution of enzymes and biosynthetic pathways. Curr. Opin. Microbiol. 9:261-67
12. Gao X, Wang P, Tang Y. 2010. Engineered polyketide biosynthesis and biocatalysis in Escherichia coli. Appl. Microbiol. Biotechnol. 88:1233-42
13. Smith S, Tsai SC. 2007. The type I fatty acid and polyketide synthases: a tale of two megasynthases. Nat. Prod. Rep. 24:1041-72
14. Cronan JE, Thomas J. 2009. Bacterial fatty acid synthesis and its relationships with polyketide synthetic pathways. Method Enzymol. 459:395-433
15. Fujii I. 2009. Heterologous expression systems for polyketide synthases. Nat. Prod. Rep. 26:155-69
16. Weissman KJ. 2009. Introduction to polyketide biosynthesis. Method Enzymol. 459:3-16
17. Fischbach MA, Walsh CT. 2006. Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem. Rev. 106:3468-96
18. Rawlings BJ. 2001. Type I polyketide biosynthesis in bacteria (part B). Nat. Prod. Rep. 18:231-81
19. Ma SM, Li JWH, Choi JW, Zhou H, Lee KKM, et al. 2009. Complete reconstitution of a highly reducing iterative polyketide synthase. Science 326:589-92
20. Khosla C, Tang Y, Chen AY, Schnarr NA, Cane DE. 2007. Structure and mechanism of the 6-deoxyerythronolide B synthase. Annu. Rev. Biochem. 76:195-221
21. Crawford JM, Townsend CA. 2010. New insights into the formation of fungal aromatic polyketides. Nat. Rev. Microbiol. 8:879-89
22. Campbell CD, Vederas JC. 2010. Biosynthesis of lovastatin and related metabolites formed by fungal iterative PKS enzymes. Biopolymers 93:755-63
23. Chooi YH, Tang Y. 2012. Navigating the fungal polyketide chemical space: from genes to molecules. J. Org. Chem. 77:9933-53
24. Hertweck C, Luzhetskyy A, Rebets Y, Bechthold A. 2007. Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork. Nat. Prod. Rep. 24:162-90
25. Yu DY, Xu FC, Zeng J, Zhan JX. 2012. Type III polyketide synthases in natural product biosynthesis. IUBMB Life 64:285-95
26. Mo S, KimDH, Lee JH, Park JW, BasnetDB, et al. 2011. Biosynthesis of the allylmalonyl-CoA extender unit for the FK506 polyketide synthase proceeds through a dedicated polyketide synthase and facilitates the mutasynthesis of analogues. J. Am. Chem. Soc. 133:976-85
27. Macherla VR,Mitchell SS, Manam RR, Reed KA, Chao T-H, et al. 2005. Structure-Activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitor. J. Med. Chem. 48:3684-87
28. An JH, Kim YS. 1998. A gene cluster encoding malonyl-CoA decarboxylase (MatA), malonyl-CoA synthetase (MatB) and a putative dicarboxylate carrier protein (MatC) in Rhizobium trifolii. Eur. J. Biochem. 257:395-402
29. Pohl NL, Hans M, Lee HY, Kim YS, Cane DE, Khosla C. 2001. Remarkably broad substrate tolerance of malonyl-CoA synthetase, an enzyme capable of intracellular synthesis of polyketide precursors. J. Am. Chem. Soc. 123:5822-23
30. Hughes AJ, Keatinge-Clay A. 2011. Enzymatic extender unit generation for in vitro polyketide synthase reactions: structural and functional showcasing of Streptomyces coelicolor Mat B. Chem. Biol. 18:165-76
31. Walker MC, Thuronyi BW, Charkoudian LK, Lowry B, Khosla C, Chang MC. 2013. Expanding the fluorine chemistry of living systems using engineered polyketide synthase pathways. Science 341:1089-94
32. Koryakina I, Williams GJ. 2011. Mutant malonyl-CoA synthetases with altered specificity for polyketide synthase extender unit generation. Chem Bio Chem 12:2289-93
33. Gokhale RS, Hunziker D, Cane DE, Khosla C. 1999. Mechanism and specificity of the terminal thioesterase domain from the erythromycin polyketide synthase. Chem. Biol. 6:117-25
34. Koryakina I, McArthur J, Randall S, Draelos MM, Musiol EM, et al. 2012. Poly specific transacyltransferase machinery revealed via engineered Acyl-CoA synthetases. ACS Chem. Biol. 8:200-8
35. Wilson MC,Moore BS. 2012. Beyond ethylmalonyl-CoA: the functional role of crotonyl-CoA carboxylase/reductase homologs in expanding polyketide diversity. Nat. Prod. Rep. 29:72-86
36. Erb TJ, Berg IA, Brecht V,M̈ ullerM, Fuchs G, Alber BE. 2007. Synthesis of C5-dicarboxylic acids from C2-units involving crotonyl-CoA carboxylase/reductase: the ethylmalonyl-CoA pathway. Proc. Natl. Acad. Sci. USA 104:10631-36
37. Erb TJ, Brecht V, Fuchs G, M̈ uller M, Alber BE. 2009. Carboxylation mechanism and stereochemistry of crotonyl-CoA carboxylase/reductase, a carboxylating enoyl-thioester reductase. Proc. Natl. Acad. Sci. USA 106:8871-76
38. Rachid S, Huo L,Herrmann J, Stadler M, K̈ opcke B, et al. 2011. Mining the cinnabaramide biosynthetic pathway to generate novel proteasome inhibitors. Chem Bio Chem 12:922-31
39. Quade N, Huo LJ, Rachid S, Heinz DW, M̈ uller R. 2012. Unusual carbon fixation gives rise to diverse polyketide extender units. Nat. Chem. Biol. 8:117-24
40. Koryakina I, McArthur JB, Draelos MM, Williams GJ. 2013. Promiscuity of a modular polyketide synthase towards natural and non-natural extender units. Org. Biomol. Chem. 11:4449-58
41. Quadri LEN, Weinreb PH, Lei M, Nakano MM, Zuber P, Walsh CT. 1998. Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetases. Biochemistry 37:1585-95
42. Yuzawa S, Eng CH, Katz L, Keasling JD. 2013. Broad substrate specificity of the loading didomain of the lipomycin polyketide synthase. Biochemistry 52:3791-93
43. Moore BS, Hertweck C. 2002. Biosynthesis and attachment of novel bacterial polyketide synthase starter units. Nat. Prod. Rep. 19:70-99
44. Xu Z, Schenk A, Hertweck C. 2007. Molecular analysis of the benastatin biosynthetic pathway and genetic engineering of altered fatty acid-polyketide hybrids. J. Am. Chem. Soc. 129:6022-30
45. Xu Z, Mets̈a-Ketel̈aM,Hertweck C. 2009. Ketosynthase III as a gateway to engineering the biosynthesis of antitumoral benastatin derivatives. J. Biotechnol. 140:107-13
46. Pan H, Tsai SC, Meadows ES, Miercke LJW, Keatinge-Clay AT, et al. 2002. Crystal structure of the priming β-ketosynthase from the R1128 polyketide biosynthetic pathway. Structure 10:1559-68
47. Bretschneider T, Zocher G, Unger M, Scherlach K, Stehle T, Hertweck C. 2012. A ketosynthase homolog uses malonyl units to form esters in cervimycin biosynthesis. Nat. Chem. Biol. 8:154-61
48. White SW, Zheng J, Zhang YM,RockCO. 2005. The structural biology of type II fatty acid biosynthesis. Annu. Rev. Biochem. 74:791-831
49. Pickens LB, KimW,Wang P, ZhouH,WatanabeK, et al. 2009. Biochemical analysis of the biosynthetic pathway of an anticancer tetracycline SF2575. J. Am. Chem. Soc. 131:17677-89
50. Zheng JT, Keatinge-Clay AT. 2013. The status of type I polyketide synthase ketoreductases. Med. Chem. Commun. 4:34-40
51. Patel RN. 2008. Synthesis of chiral pharmaceutical intermediates by biocatalysis. Coord. Chem. Rev. 252:659-701
52. O'Hare HM, Baerga-Ortiz A, Popovic B, Spencer JB, Leadlay PF. 2006. High-throughput mutagenesis to evaluatemodels of stereochemical control in ketoreductase domains from the erythromycin polyketide synthase. Chem. Biol. 13:287-96
53. Castonguay R, He W, Chen AY, Khosla C, Cane DE. 2007. Stereospecificity of ketoreductase domains of the 6-deoxyerythronolide B synthase. J. Am. Chem. Soc. 129:13758-69
54. Keatinge-Clay AT. 2007. A tylosin ketoreductase reveals how chirality is determined in polyketides. Chem. Biol. 14:898-908
55. Zheng J, Taylor CA, Piasecki SK, Keatinge-Clay AT. 2010. Structural and functional analysis of A-type ketoreductases from the amphotericin modular polyketide synthase. Structure 18:913-22
56. Bali S, O'Hare HM, Weissman KJ. 2006. Broad substrate specificity of ketoreductases derived from modular polyketide synthases. Chem Bio Chem 7:478-84
57. Piasecki SK, Taylor CA, Detelich JF, Liu J, Zheng J, et al. 2011. Employingmodular polyketide synthase ketoreductases as biocatalysts in the preparative chemoenzymatic syntheses of diketide chiral building blocks. Chem. Biol. 18:1331-40
58. Harper AD, Bailey CB, Edwards AD, Detelich JF, Keatinge-Clay AT. 2012. Preparative, in vitro biocatalysis of triketide lactone chiral building blocks. Chem Bio Chem 13:2200-3
59. Kellenberger L, Galloway IS, Sauter G, B̈ohm G, Hanefeld U, et al. 2008. A polylinker approach to reductive loop swaps in modular polyketide synthases. Chem Bio Chem 9:2740-49
60. Ding W, Lei C, He QL, Zhang QL, Bi YR, Liu W. 2010. Insights into bacterial 6-methylsalicylic acid synthase and its engineering to orsellinic acid synthase for spirotetronate generation. Chem. Biol. 17:495-503
61. Olano C, Ḿendez C, Salas JA. 2010. Post-PKS tailoring steps in natural product-producing actinomycetes from the perspective of combinatorial biosynthesis. Nat. Prod. Rep. 27:571-616
62. Jacobsen JR, Hutchinson CR, Cane DE, Khosla C. 1997. Precursor-directed biosynthesis of erythromycin analogs by an engineered polyketide synthase. Science 277:367-69
63. Walsh CT, Wencewicz TA. 2013. Flavoenzymes: versatile catalysts in biosynthetic pathways. Nat. Prod. Rep. 30:175-200
64. Podust LM, Sherman DH. 2012. Diversity of P450 enzymes in the biosynthesis of natural products. Nat. Prod. Rep. 29:1251-66
65. Kharel MK, Pahari P, Shepherd MD, Tibrewal N, Nybo SE, et al. 2012. Angucyclines: biosynthesis, mode-of-Action, new natural products, and synthesis. Nat. Prod. Rep. 29:264-325
66. Xie X, Watanabe K,WojcickiWA, Wang CC, Tang Y. 2006. Biosynthesis of lovastatin analogs with a broadly specific acyltransferase. Chem. Biol. 13:1161-69
67. Xie XK, Tang Y. 2007. Efficient synthesis of simvastatin by use of whole-cell biocatalysis. Appl. Environ. Microbiol. 73:2054-60
68. Gao X, Xie X, Pashkov I, Sawaya MR, Laidman J, et al. 2009. Directed evolution and structural characterization of a simvastatin synthase. Chem. Biol. 16:1064-74
69. Newbert RW, Barton B, Greaves P, Harper J, Turner G. 1997. Analysis of a commercially improved Penicillium chrysogenum strain series: involvement of recombinogenic regions in amplification and deletion of the penicillin biosynthesis gene cluster. J. Ind. Microbiol. Biotechnol. 19:18-27
70. Fierro F, Barredo JL, D́ez B, Gutierrez S, Ferńandez FJ, Mart́n JF. 1995. The penicillin gene cluster is amplified in tandem repeats linked by conserved hexanucleotide sequences. Proc. Natl. Acad. Sci. USA 92:6200-4
71. Nijland JG, Ebbendorf B, Woszczynska M, Boer R, Bovenberg RAL, Driessen AJM. 2010. Nonlinear biosynthetic gene cluster dose effect on penicillin production by Penicillium chrysogenum. Appl. Environ. Microbiol. 76:7109-15
72. Weber SS, Polli F, Boer R, Bovenberg RAL, Driessen AJM. 2012. Increased penicillin production in Penicillium chrysogenum production strains via balanced overexpression of isopenicillinNacyltransferase. Appl. Environ. Microbiol. 78:7107-13
73. Loncaric C, Merriweather E,Walker KD. 2006. Profiling a taxol pathway 10β-Acetyltransferase: assessment of the specificity and the production of baccatin III by in vivo acetylation. E. coli. Chem. Biol. 13:309-17
74. Ondari ME,Walker KD. 2008. The taxol pathway 10-O-Acetyltransferase shows regioselective promiscuity with the oxetane hydroxyl of 4-deacetyltaxanes. J. Am. Chem. Soc. 130:17187-94
75. Garća B, Gonźalez-Sab́n J, Meńendez N, Brãna AF, Nu ̃ nez LE, et al. 2011. The chromomycin CmmA acetyltransferase: a membrane-bound enzyme as a tool for increasing structural diversity of the antitumour mithramycin. Microbiol. Biotechnol. 4:226-38
76. Meńendez N, Nur-e-Alam M, Bra ̃ na AF, Rohr J, Salas JA, Ḿendez C. 2004. Tailoring modification of deoxysugars during biosynthesis of the antitumour drug chromomycin A3 by Streptomyces griseus ssp. griseus. Mol. Microbiol. 53:903-15
77. Ḿendez C, Salas JA. 2001. Altering the glycosylation pattern of bioactive compounds. Trends Biotechnol. 19:449-56
78. Weymouth-Wilson AC. 1997. The role of carbohydrates in biologically active natural products. Nat. Prod. Rep. 14:99-110
79. Ahmed A, Peters NR, Fitzgerald MK, Watson JA, Hoffmann FM, Thorson JS. 2006. Colchicine glycorandomization influences cytotoxicity and mechanism of action. J. Am. Chem. Soc. 128:14224-25
80. Thibodeaux CJ, Melançon CE, Liu H-W. 2008. Natural-product sugar biosynthesis and enzymatic glycodiversification. Angew. Chem. Int. Ed. 47:9814-59
81. Williams GJ, Zhang C, Thorson JS. 2007. Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution. Nat. Chem. Biol. 3:657-62
82. Williams GJ, Thorson JS. 2008. A high-throughput fluorescence-based glycosyltransferase screen and its application in directed evolution. Nat. Protoc. 3:357-62
83. Williams GJ, Goff RD, Zhang CS, Thorson JS. 2008. Optimizing glycosyltransferase specificity via "hot spot" saturation mutagenesis presents a catalyst for novobiocin glycorandomization. Chem. Biol. 15:393-401
84. Park S-H, Park H-Y, Cho B-K, Yang Y-H, Sohng JK, et al. 2009. Reconstitution of antibiotics glycosylation by domain exchanged chimeric glycosyltransferase. J. Mol. Catal. B 60:29-35
85. Krauth C, Fedoryshyn M, Schleberger C, Luzhetskyy A, Bechthold A. 2009. Engineering a function into a glycosyltransferase. Chem. Biol. 16:28-35
86. Cartwright AM, Lim E-K, Kleanthous C, Bowles DJ. 2008. A kinetic analysis of regiospecific glucosylation by two glycosyltransferases of Arabidopsis thaliana: domain swapping to introduce new activities. J. Biol. Chem. 283:15724-31
87. Mulichak AM, Losey HC, Lu W, Wawrzak Z, Walsh CT, Garavito RM. 2003. Structure of the TDPepi-vancosaminyltransferase GtfA from the chloroeremomycin biosynthetic pathway. Proc. Natl. Acad. Sci. USA 100:9238-43
88. Hu Y, Chen L, Ha S, Gross B, Falcone B, et al. 2003. Crystal structure of the MurG:UDP-GlcNAc complex reveals common structural principles of a superfamily of glycosyltransferases. Proc. Natl. Acad. Sci. USA 100:845-49
89. Truman AW, Dias MVB, Wu S, Blundell TL, Huang FL, Spencer JB. 2009. Chimeric glycosyltransferases for the generation of hybrid glycopeptides. Chem. Biol. 16:676-85
90. Zhang CS, Griffith BR, Fu Q, Albermann C, Fu X, et al. 2006. Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions. Science 313:1291-94
91. GanttRW, Peltier-Pain P, Cournoyer WJ, Thorson JS. 2011. Using simple donors to drive the equilibria of glycosyltransferase-catalyzed reactions. Nat. Chem. Biol. 7:685-91
92. Williams GJ, Yang J, Zhang C, Thorson JS. 2010. Recombinant E. coli prototype strains for in vivo glycorandomization. ACS Chem. Biol. 6:95-100
93. Gantt RW, Goff RD, Williams GJ, Thorson JS. 2008. Probing the aglycon promiscuity of an engineered glycosyltransferase. Angew. Chem. Int. Ed. 47:8889-92
94. Peltier-Pain P, Marchillo K, Zhou MQ, Andes DR, Thorson JS. 2012. Natural product disaccharide engineering through tandem glycosyltransferase catalysis reversibility and neoglycosylation. Org. Lett. 14:5086-89
95. Gantt RW, Peltier-Pain P, Singh S, Zhou MQ, Thorson JS. 2013. Broadening the scope of glycosyltransferase-catalyzed sugar nucleotide synthesis. Proc. Natl. Acad. Sci. USA 110:7648-53
96. Chen R, Zhang H, Zhang G, Li S, Zhang G, et al. 2013. Characterizing amosamine biosynthesis in amicetin reveals AmiG as a reversible retaining glycosyltransferase. J. Am. Chem. Soc. 135:12152-55
97. Vaillancourt FH, Yeh E, Vosburg DA, Garneau-Tsodikova S, Walsh CT. 2006. Nature's inventory of halogenation catalysts: oxidative strategies predominate. Chem. Rev. 106:3364-78
98. HernandesMZ, Cavalcanti SMT, Moreira DRM, de Azevedo WF, Leite ACL. 2010. Halogen atoms in the modern medicinal chemistry: hints for the drug design. Curr. Drug Targets 11:303-14
99. Yeh E, Cole LJ, Barr EW, Bollinger JM, Ballou DP, Walsh CT. 2006. Flavin redox chemistry precedes substrate chlorination during the reaction of the flavin-dependent halogenase RebH. Biochemistry 45:7904-12
100. Glenn WS, Nims E, O'Connor SE. 2011. Reengineering a tryptophan halogenase to preferentially chlorinate a direct alkaloid precursor. J. Am. Chem. Soc. 133:19346-49
101. Payne JT, Andorfer MC, Lewis JC. 2013. Regioselective arene halogenation using the FAD-dependent halogenase RebH. Angew. Chem. Int. Ed. 52:5271-74
102. Zeng J, Zhan J. 2010. A novel fungal flavin-dependent halogenase for natural product biosynthesis. Chem Bio Chem 11:2119-23
103. Zhu T, Cheng X, Liu Y,Deng Z, You D. 2013. Deciphering and engineering of the final step halogenase for improved chlortetracycline biosynthesis in industrial Streptomyces aureofaciens. Metab. Eng. 19:69-78
104. Dong CJ, Huang FL, Deng H, Schaffrath C, Spencer JB, et al. 2004. Crystal structure and mechanism of a bacterial fluorinating enzyme. Nature 427:561-65
105. Neumann CS, Fujimori DG, Walsh CT. 2008. Halogenation strategies in natural product biosynthesis. Chem. Biol. 15:99-109
106. Eustaquio AS, Pojer F, Noe JP, Moore BS. 2008. Discovery and characterization of a marine bacterial SAM-dependent chlorinase. Nat. Chem. Biol. 4:69-74
107. EustaquioAS, MooreBS. 2008. Mutasynthesis of fluorosalinosporamide, a potent and reversible inhibitor of the proteasome. Angew. Chem. Int. Ed. 47:3936-38
108. Piel J. 2010. Natural products via enzymatic reactions. Preface. Top. Curr. Chem. 297:ix-x
109. Sattely ES, Fischbach MA, Walsh CT. 2008. Total biosynthesis: in vitro reconstitution of polyketide and nonribosomal peptide pathways. Nat. Prod. Rep. 25:757-93
110. Xiang L, Kalaitzis JA, Moore BS. 2004. EncM, a versatile enterocin biosynthetic enzyme involved in Favorskii oxidative rearrangement, aldol condensation, and heterocycle-forming reactions. Proc. Natl. Acad. Sci. USA 101:15609-14
111. Cheng Q, Xiang L, Izumikawa M, Meluzzi D, Moore BS. 2007. Enzymatic total synthesis of enterocin polyketides. Nat. Chem. Biol. 3:557-58
112. Kalaitzis JA, Cheng Q, Thomas PM, Kelleher NL, Moore BS. 2009. In vitro biosynthesis of unnatural enterocin and wailupemycin polyketides. J. Nat. Prod. 72:469-72
113. Pahari P, Kharel MK, Shepherd MD, van Lanen SG, Rohr J. 2012. Enzymatic total synthesis of defucogilvocarcin M and its implications for gilvocarcin biosynthesis. Angew. Chem. Int. Ed. 51:1216-20
114. Hansen DA, Rath CM, Eisman EB, Narayan AR, Kittendorf JD, et al. 2013. Biocatalytic synthesis of pikromycin, methymycin, neomethymycin, novamethymycin, and ketomethymycin. J. Am. Chem. Soc. 135:11232-38
115. Mortison JD, Kittendorf JD, Sherman DH. 2009. Synthesis and biochemical analysis of complex chainelongation intermediates for interrogation of molecular specificity in the erythromycin and pikromycin polyketide synthases. J. Am. Chem. Soc. 131:15784-93
116. Zhang W, Ntai I, Bolla ML, Malcolmson SJ, Kahne D, et al. 2011. Nine enzymes are required for assembly of the pacidamycin group of peptidyl nucleoside antibiotics. J. Am. Chem. Soc. 133:5240-43
117. Cacho RA, Chooi YH, ZhouH, Tang Y. 2013. Complexity generation in fungal polyketide biosynthesis: a spirocycle-forming P450 in the concise pathway to the antifungal drug griseofulvin. ACS Chem. Biol. 8:2322-30